Olema Pharmaceuticals, Inc. (OLMA)
7.07
-0.29
(-3.94%)
USD |
NASDAQ |
Oct 13, 14:02
Olema Pharmaceuticals EPS Diluted (Quarterly) : -0.605 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.605 |
| March 31, 2026 | -0.5164 |
| December 31, 2025 | -0.5044 |
| September 30, 2025 | -0.4924 |
| June 30, 2025 | -0.5121 |
| March 31, 2025 | -0.3557 |
| December 31, 2024 | -0.4517 |
| September 30, 2024 | -0.6034 |
| June 30, 2024 | -0.5398 |
| March 31, 2024 | -0.5573 |
| December 31, 2023 | -0.4887 |
| September 30, 2023 | -0.4781 |
| June 30, 2023 | -0.4935 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.7009 |
| December 31, 2022 | -0.6514 |
| September 30, 2022 | -0.5675 |
| June 30, 2022 | -0.8231 |
| March 31, 2022 | -0.5781 |
| December 31, 2021 | -0.5444 |
| September 30, 2021 | -0.4472 |
| June 30, 2021 | -0.4162 |
| March 31, 2021 | -0.39 |
| December 31, 2020 | -0.2577 |
| September 30, 2020 | -0.2522 |
| June 30, 2020 | -0.0624 |
| March 31, 2020 | -0.0431 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| SELLAS Life Sciences Group, Inc. | -0.0508 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -63.20M |
| Total Expenses (Quarterly) | 63.20M |
| Enterprise Value | 186.24M |
| Earnings Yield | -29.96% |
| Normalized Earnings Yield | -29.96 |